Valuation check: DRRX's profit margin is 221.81%, above the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2025
Trailing 12 months ending Jun 2025
Durect (DRRX) currently reports a profit margin of 221.81% as of June 2025. That compares with -187.84% in the prior-year period — up 218.1% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore Durect's profit margin history and peer comparisons.
Durect's profit margin increased from -187.84% to 221.81% — a 218.1% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Durect's profit margin of 221.81% is higher than the Healthcare sector average of 13.89%. That is roughly 1496.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Durect's current 221.81% should be judged against Healthcare norms (sector average: 13.89%) and against DRRX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 221.81%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Durect, and consider following DRRX for alerts when major investors trade the stock.